Antigen-specific T cells are a powerful tool for understanding human immunity and developing treatments and cures for our most prolific diseases. Luckily, they are more readily available to researchers than ever before. Not only have we devoted many resources over the past several years to developing an exclusive inventory of antigen-specific T cells for use…
We are headed to the American Association for Cancer Research’s 2019 annual meeting in Atlanta! We will be at the show from March 31 – April 3 in booth #4907 to answer your immunology research questions and highlight our latest immune cell developments. If you will be in Atlanta for AACR, save this list of…
Cancer Patients Give Blood Cells to Advance Treatment Studies Cancer patients are fighting back and helping advance the development of cutting edge cancer treatments by giving blood cells for laboratory medical research. Patients giving small amounts of white blood cells allow preclinical scientists to study the potential effectiveness and critical safety of innovative immune treatments.…
MART-1 (melanoma antigen recognized by T cells 1) is a “widely shared melanoma antigen recognized by the T lymphocytes of patients with established malignancy.” MART-1 is one of the oldest identified tumor antigens and is a protein found on normal melanocytes in the skin and retina. It is also found in most melanomas, cancers that…
Scientific studies directly or indirectly involving human immunity require an understanding of both sides of the complex system. Even the development of an adaptive antigen-specific cell-based therapy requires components of the innate immune system that work in concert with the adaptive cells. If you don’t work primarily in immunology, this post will give you a…